Prot# EMR 62 225: Feasibility Study on the Use of A Parkinson's Disease Symptoms Diary for the Planned Phase III Studies with Sarizotan (EMR 62 225)

Project: Research project

Project Details

StatusFinished
Effective start/end date6/14/04 → 8/12/05

Funding

  • Monitoring Force USA, Inc. (EMR 62 225)
  • Merck KGaA (EMR 62 225)